-
PDF
- Split View
-
Views
-
Cite
Cite
T Bucci, A Shantsila, G F Romiti, W S Teo, H W Park, W Shimizu, H F Tse, M Proietti, G Y H Lip, T F Chao, Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators , ABC (Atrial fibrillation Better Care) pathway in asian patients: an analysis from the prospective Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry, European Heart Journal, Volume 44, Issue Supplement_2, November 2023, ehad655.406, https://doi.org/10.1093/eurheartj/ehad655.406
- Share Icon Share
Abstract
The "Atrial fibrillation Better Care" (ABC) has been proposed as an integrated approach to improve management in patients with atrial fibrillation (AF) based on 3 pillars: "A" Avoid stroke with Anticoagulation; "B" Better symptom optimisation through rate or rhythm control; "C" Cardiovascular risk factor management. There are limited prospective data on the clinical outcomes associated with ABC pathway adherence from Asian countries.
To investigate the beneficial effect of ABC pathway adherence in the prospective multi-country Asia-Pacific Heart Rhythm Society (APHRS) Atrial Fibrillation registry.
We investigated 4013 AF patients prospectively enrolled in the APHRS registry. Cox-regression analyses were performed to investigate the association between ABC adherence and clinical outcomes. Primary outcome was a composite of all-cause death, any thromboembolic events, acute coronary syndrome or percutaneous interventional procedures and new/worsening heart failure. Secondary outcomes were each component of the composite outcome and major bleeding.
In the whole population, 1549 (38.6%) patients were ABC adherent (mean age 66±12 years; 33% female). After 1-year of follow-up, ABC pathway adherent patients had a lower incidence of composite outcome (4.0% vs 8.5%, p<0.001), all-cause death (1.4% vs 4.0%, p<0.001), cardiovascular death (0.3% vs 0.9%, p=0.013) and new/worsening heart failure (1.7% vs 2.7%, p=0.010), when compared to those ABC non-adherent. On multivariable Cox regression ABC pathway adherence was associated with a lower risk for composite outcome (Hazard Ratio 0.72, 95% Confidence Interval 0.53-0.97) and the reduction of the risk increased progressively with the number of the ABC criteria fulfilled. There was no statistically significant interaction in the clinical benefit seen between the different participating countries in the APHRS registry (pint=0.217).
Author notes
Funding Acknowledgements: Type of funding sources: Private company. Main funding source(s): This study was an independent research grant by Pfizer and Bristol Myers Squibb (BMS) to Asia-Pacific Heart Rhythm Society
- acute coronary syndromes
- anticoagulation
- atrial fibrillation
- heart disease risk factors
- hemorrhage
- cerebrovascular accident
- ischemic stroke
- heart failure
- asia
- follow-up
- treatment outcome
- thromboembolic event
- risk reduction
- cardiovascular event
- cox proportional hazards models
- cardiac rhythm
- cardiovascular death
- asian
- rhythm
- primary outcome measure
- composite outcomes